News

AM-Pharma B.V., a clinical stage biopharmaceutical company, leading in the development of a treatment for acute kidney injury (AKI) with its innovative recombinant human Alkaline…
Read More...

Kite, a Gilead Company (Nasdaq: GILD), announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and manufacturing of viral vectors, a…
Read More...

Sosei Group Corporation announces that it has entered into a multi-target research collaboration and license agreement with Genentech, a member of the Roche Group, to discover and…
Read More...

Dicerna Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation (BTD) to DCR-PHXC for the treatment of patients…
Read More...

AbbVie, a research-based global biopharmaceutical company, announced that it has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel…
Read More...

Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing…
Read More...

SOTIO and Cytune Pharma, members of the PPF Group, announce the first dosing of cancer patients with SO-C101, a superagonist fusion protein of interleukin IL-15. The phase I/Ib study…
Read More...

Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, announced that it has entered into…
Read More...

Teva Pharmaceuticals USA, Inc. announced that the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa., which, together with three other…
Read More...

Nexus Pharmaceuticals Inc., woman-owned, privately held, US-based healthcare company, announced an agreement with the village of Pleasant Prairie, Wisconsin to build an industry-leading…
Read More...

Jazz Pharmaceuticals plc announced that the company has signed a definitive agreement under which Jazz has acquired Redx Pharma's (Redx) pan-RAF inhibitor program for the potential…
Read More...

The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for isatuximab for the treatment of patients with relapsed/refractory…
Read More...

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced a new sealing solution for tamper-proof closure of…
Read More...

Ligand Pharmaceuticals Incorporated announced positive top line results from a Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol program. The CE-Iohexol program was…
Read More...

Celsius Therapeutics, a company focused on the discovery and development of precision therapeutics for patients with autoimmune diseases and cancer, announced a collaboration with…
Read More...

MacroGenics, Inc. and I-Mab Biopharma (I-Mab) announced that the companies have entered into an exclusive collaboration and license agreement to develop and commercialize enoblituzumab.…
Read More...

Catalent, Inc. announced that it has significantly expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredient Solutions, an…
Read More...

ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is now offering off-target toxicity and linker stability assay…
Read More...

CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody therapeutic…
Read More...

Lonza announced the completion of a $15M multi-phase expansion of its solid oral dose development and manufacturing capabilities and capacity at its Tampa, FL (USA) site. The expansion…
Read More...